RT Journal Article
SR Electronic
T1 Kidney impairment is associated with in-hospital death of COVID-19 patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.02.18.20023242
DO 10.1101/2020.02.18.20023242
A1 Cheng, Yichun
A1 Luo, Ran
A1 Wang, Kun
A1 Zhang, Meng
A1 Wang, Zhixiang
A1 Dong, Lei
A1 Li, Junhua
A1 Yao, Ying
A1 Ge, Shuwang
A1 Xu, Gang
YR 2020
UL http://medrxiv.org/content/early/2020/02/20/2020.02.18.20023242.abstract
AB Background Information on kidney impairment in patients with coronavirus disease 2019 (COVID-19) is limited. This study aims to assess the prevalence and impact of abnormal urine analysis and kidney dysfunction in hospitalized COVID-19 patients in Wuhan.Methods We conducted a consecutive cohort study of COVID-19 patients admitted in a tertiary teaching hospital with 3 branches following a major outbreak in Wuhan in 2020. Hematuria, proteinuria, serum creatinine concentration and other clinical parameters were extracted from the electronic hospitalization databases and laboratory databases. Incidence rate for acute kidney injury (AKI) was examined during the study period. Association between kidney impairment and in-hospital death was analyzed.Results We included 710 consecutive COVID-19 patients, 89 (12.3%) of whom died in hospital. The median age of the patients was 63 years (inter quartile range, 51-71), including 374 men and 336 women. On admission, 44% of patients have proteinuria hematuria and 26.9% have hematuria, and the prevalence of elevated serum creatinine and blood urea nitrogen were 15.5% and 14.1% respectively. During the study period, AKI occurred in 3.2% patients. Kaplan–Meier analysis demonstrated that patients with kidney impairment have higher risk for in-hospital death. Cox proportional hazard regression confirmed that elevated serum creatinine, elevated urea nitrogen, AKI, proteinuria and hematuria was an independent risk factor for in-hospital death after adjusting for age, sex, disease severity, leukocyte count and lymphocyte count.Conclusions The prevalence of kidney impairment (hematuria, proteinuria and kidney dysfunction) in hospitalized COVID-19 patients was high. After adjustment for confounders, kidney impairment indicators were associated with higher risk of in-hospital death. Clinicians should increase their awareness of kidney impairment in hospitalized COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was financially supported by international (regional) cooperation and exchange projects, (NSFC-DFG, Grant No. 81761138041), the Major Research plan of the National Natural Science Foundation of China (Grant No. 91742204), the National Natural Science Foundation of China (Grants 81470948, 81670633, 81570667), the National Key Research and Development Program (Grants 2016YFC0906103, 2018YFC1314000) and the National Key Technology R&D Program (Grant 2013BAI09B06, 2015BAI12B07).Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets used and analysed during the current study are available from the corresponding author on reasonable request95% CI95% confidence interval;ACE2angiotensin converting enzyme IIAKIAcute kidney injury;BUNBlood urea nitrogenCKDChronic kidney disease;CKD-EPIChronic Kidney Disease Epidemiology CollaborationCOVID-19Coronavirus disease 2019eGFREstimated glomerular filtration rateHRHazard ratioICUIntensive care unitKDIGOKidney Disease Improving Global Outcomes;SARSSevere acute respiratory syndromeSARS-CoV-2Severe acute respiratory syndrome coronavirus 2ScrSerum creatinine;WHOWorld health organization;